Journal article
PB2129: THE MODAKAFUSP ALFA IINNOVATE CLINICAL DEVELOPMENT PROGRAM: RATIONALE AND DESIGN OF 3 PHASE 1/2 TRIALS OF AN INNATE IMMUNITY ENHANCER FOR MULTIPLE MYELOMA (MM)
Authors
Holstein SA; Mian H; Touzeau C; Kingsley E; Vogl D; Zuniga R; Suryanarayan K; Wang S; Thesillat‐Versmee L; Liu Y
Journal
HemaSphere, Vol. 7, No. Suppl,
Publisher
Wiley
Publication Date
August 8, 2023
DOI
10.1097/01.hs9.0000975280.98608.35
ISSN
2572-9241